MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Dec. 13, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) announced today that it will supply private-label
diode laser systems exclusively to AngioDynamics, Inc. (Nasdaq: ANGO)
to sell and market for peripheral vascular treatments.
In September 2007 AngioDynamics and PhotoMedex entered into a
three-year OEM agreement under which PhotoMedex manufactures for
AngioDynamics, on a non-exclusive basis, a private-label,
980-nanometer diode laser system. The sy...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Nov. 23, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) announced today that it received notification from
The Nasdaq Stock Market ("Nasdaq") on November 19, 2007 that the
Company was not in compliance with the $1.00 minimum bid price
requirement for continued listing on Nasdaq's Global Market exchange
under Marketplace Rule 4450(a)(5). Such a notification letter is
standard when the bid price of a Nasdaq-listed company closes below a
$1.00 per share bid p...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Nov. 1, 2007--PhotoMedex,
Inc. (NASDAQ:PHMD) today announced financial and operating results for
the three months ended September 30, 2007. Financial highlights of the
2007 third quarter include:
Domestic XTRAC(R) procedures up 39% over the prior-year third
quarter and essentially unchanged sequentially
Domestic XTRAC treatment revenues up 36% over the prior-year
third quarter and up 12% sequentially
Domestic XT...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Oct. 30, 2007--PhotoMedex
(Nasdaq:PHMD) will participate in the Acumen BioFin Rodman & Renshaw
9th Annual Healthcare Conference being held from November 5-7, 2007 at
the New York Palace Hotel in New York. The Company's presentation is
scheduled to begin at 2:00 p.m. Eastern Time on November 5, 2007.
Representing PhotoMedex will be Jeffrey O'Donnell, president and chief
executive officer, and Dennis McGrath, chief financial officer and
vice presid...
MONTGOMERYVILLE, Penn.--(BUSINESS WIRE)--Oct. 26, 2007--In BW5106
issued Oct. 26, 2007: Please note PhotoMedex ranking in release should
be eighth (sted 10th). This change is reflected in the headline and
second graph, second sentence.
The corrected release reads:
PHOTOMEDEX RANKED EIGHTH IN DELOITTE'S TECHNOLOGY FAST 50 PROGRAM
FOR GREATER PHILADELPHIA
PhotoMedex (Nasdaq:PHMD) has been named to Deloitte's prestigious
Technology Fast 50 Program for Greater Philadelphia, a...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Oct. 25, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) will hold a conference call to discuss the
Company's third quarter 2007 results on Thursday, November 1, 2007 at
4:30 p.m. Eastern Time.
The third quarter results will be announced on November 1st, prior
to the conference call.
To participate in the conference call, dial 877-681-3373 (and
confirmation code # 4189561) approximately 5 to 10 minutes prior to
the scheduled start time. If you are ...
PhotoMedex to Expand Marketing Effort Throughout These States
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Oct. 4, 2007--PhotoMedex
(Nasdaq:PHMD) today announced that Blue Cross and Blue Shield of
Illinois, Blue Cross and Blue Shield of New Mexico, Blue Cross and
Blue Shield of Oklahoma, and Blue Cross and Blue Shield of Texas, all
divisions of Health Care Service Corporation (HCSC), have adopted a
medical policy effective October 15, 2007 approving payment for
treatment of psoriasis us...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Sept. 18, 2007--PhotoMedex,
Inc. (Nasdaq: PHMD) today announced the appointment of Paul TanPiengco
to the position of Director of Marketing. He will report directly to
Jeff O'Donnell, President and CEO. Most recently, Mr. TanPiengco was
Director of Product Management at Onset Therapeutics, a Rhode Island
based wound care and dermatology company, where he was responsible for
developing and implementing sales and marketing strategies including
the ...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Aug. 28, 2007--PhotoMedex,
Inc. (NASDAQ: PHMD) will participate in the Roth Capital Partners ROTH
2007 New York Conference being held September 5-6, 2007 at The Westin
New York in Times Square. The Company's presentation is scheduled to
begin at 3:30 p.m. Eastern time on September 6. Representing
PhotoMedex will be Jeffrey O'Donnell, president and chief executive
officer, and Dennis McGrath, chief financial officer and vice
president of finance.
...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Aug. 14, 2007--PhotoMedex,
Inc. (NASDAQ:PHMD) will present at the Noble Financial Equity
Conference being held on August 20, and 21, 2007 at the Charleston
Place Hotel in Charleston, South Carolina.
On August 21, 2007 at 11:30 a.m. ET, Jeffrey O'Donnell, president
and chief executive officer, will give a 25-minute presentation
regarding PhotoMedex's history, products, financial performance and
prospects. Dennis McGrath, chief financial office...
MD Lash Factor(R) Produces Results in as Little as One Week
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Aug. 2, 2007--PhotoMedex
(Nasdaq:PHMD) announced that its clinically proven MD Lash Factor(R)
will be launched at the summer conference of the American Academy of
Dermatology (AAD) in New York today. For patients with thin or
thinning eyelashes, this latest technology breakthrough promotes the
appearance of longer, fuller, thicker eyelashes in as little as one
week.
"We are plea...
MONTGOMERYVILLE, Penn.--(BUSINESS WIRE)--Aug. 2, 2007--PhotoMedex,
Inc. (NASDAQ:PHMD) today announced financial and operating results for
the three months ended June 30, 2007. Financial highlights of the 2007
second quarter include:
Domestic XTRAC(R) procedures up 30% over the prior-year second
quarter and up 11% sequentially
Domestic XTRAC(R) revenues up 67% over the prior-year second
quarter and up 23% sequentially
XTRAC(R) gross prof...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Aug. 2, 2007--PhotoMedex(R)
(Nasdaq:PHMD) announces that it has retained the firm of Boyd Tamney
Cross as its public relations agency of record. Under the agreement,
Boyd Tamney Cross will promote the XTRAC(R) Excimer Laser System. The
agency will promote the XTRAC System in the dermatology trade,
consumer and business to business markets by generating and
distributing regular news releases and peer review and non-peer review
articles; building b...
Neova(R) Manganese Skin Brightening Serum Defends Against
UV-Induced Aging
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Aug. 1, 2007--PhotoMedex
(Nasdaq:PHMD) announced that ProCyte will launch its new Neova(R)
Manganese Skin Brightening Serum(a) in October 2007. This unique,
anti-aging serum is the only clinically proven formula that uses GHK
Manganese Peptide Complex(TM), which is involved in the defense
against UV-induced aging.
"This latest addition t...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--July 26, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) will hold a conference call to discuss the
Company's second quarter 2007 results on Thursday, August 2, 2007 at
4:30 p.m. Eastern Time.
The second quarter results will be announced on August 2nd, prior
to the conference call.
To participate in the conference call, dial 877-704-5384 (and
confirmation code # 2351514) approximately 5 to 10 minutes prior to
the scheduled start time. If you are un...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--May 30, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) today announced that Jeffrey O'Donnell, president
and chief executive officer, and Dennis McGrath, chief financial
officer and vice president of finance, will present at the 2007 FBR
Growth Conference on Thursday, May 31, at 12:50 p.m. ET. The
conference will be held at the Grand Hyatt Hotel in New York City from
May 30 - May 31, 2007.
A live webcast of the presentation will be available by going...
MONTGOMERYVILLE, Pa., May 03, 2007 (BUSINESS WIRE) -- PhotoMedex, Inc. (Nasdaq:PHMD) announces the appointment of
Stephen P. Connelly to the Board of Directors.
Stephen P. Connelly has over twenty-five years of experience in
the planning, development and management of rapid-growth
marketing-driven businesses in the medical device and pharmaceutical
fields. He has served as President and Chief Operating Officer of
Viasys Healthcare, Inc. a publicly traded medical technology and
device comp...
Sets Annual Stockholders' Meeting for June 26, 2007MONTGOMERYVILLE, Pa., May 03, 2007 (BUSINESS WIRE) -- PhotoMedex, Inc. (NASDAQ:PHMD) today announced financial and
operating results for the quarter ended March 31, 2007. Financial
highlights of the 2007 first quarter include:
-- Domestic XTRAC(R) procedures up 32% from the prior-year first
quarter and up 12% sequentially
-- Domestic XTRAC(R) revenues up 71% from the prior-year first
quarter
-- XTRAC(R) gross profit...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--April 26, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) will hold a conference call to discuss the
Company's first quarter 2007 results on Thursday, May 3, 2007, at 4:30
p.m. Eastern Time.
The first quarter results will be announced on May 3rd, prior to
the conference call.
To participate in the conference call, dial 877-502-9274 (and
confirmation code # 6084572) approximately 5 to 10 minutes prior to
the scheduled start time. If you are unable t...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--March 15, 2007--PhotoMedex
(Nasdaq: PHMD) today announced that the Blue Cross Blue Shield
Association (BCBSA) has revised the portion of its National Reference
Policy that includes the PhotoMedex(R) XTRAC(R) Laser System's
treatment of psoriasis. The Policy now states that the XTRAC Laser may
be considered medically necessary for the treatment of mild to
moderate psoriasis that is unresponsive to conservative treatment, and
further states that th...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--March 7, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) announced today that Jeffrey O'Donnell, its
president and chief executive officer, and Dennis McGrath, its chief
financial officer and vice president of finance, will present at the
Cowen and Company 27th Annual Health Care Conference on Wednesday,
March 14, 10:15 a.m. ET. The conference will be held at the Boston
Marriott Copley Place Hotel in Boston, Massachusetts from March 12 -
March 15, 2007.
...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--March 1, 2007--PhotoMedex,
Inc. (NASDAQ:PHMD) today announced financial and operating results for
the three and 12 months ended December 31, 2006. Financial highlights
of the 2006 fourth quarter include:
XTRAC(R) procedures up 51% from the prior-year fourth quarter
and up 15% sequentially
XTRAC(R) revenues up 63% from the prior-year fourth quarter
XTRAC(R) gross profit up 85% from the prior-year fourth
...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Feb. 22, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) will hold a conference call to discuss the
Company's fourth quarter 2006 results on Thursday, March 1, 2007 at
4:30 p.m. Eastern Time.
The fourth quarter results will be announced on March 1st, prior
to the conference call.
To participate in the conference call, dial 800-811-8824 (and
confirmation code # 9818542) approximately 5 to 10 minutes prior to
the scheduled start time. If you are ...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Feb. 15, 2007--PhotoMedex,
Inc. (Nasdaq:PHMD) announced today that Jeff O'Donnell, president and
chief executive officer, and Dennis McGrath, chief financial officer,
will present at the Roth Capital Partners 19th Annual OC Conference on
Thursday, February 22, 2007 at 8:30 a.m. PT. The conference will be
held at the Ritz Carlton Hotel in Laguna Niguel, California from
February 19 - 22, 2007.
A live webcast of the panel discussion will be avai...
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Jan. 19, 2007--PhotoMedex,
Inc. (Nasdaq: PHMD), a provider of healthcare solutions, today
announced the launch of its new corporate website. The completely
redesigned site, which is located at PhotoMedex's current URL of
www.photomedex.com, contains new features such as site search
functionality and improved navigation.
PhotoMedex made the strategic decision to consolidate the
corporate websites of both Procyte (www.procyte.com) and Surgical
...
